Actuate Therapeutics宣布难治性儿科癌症一期试验取得积极患者成果

美股速递
Jan 06

生物制药公司Actuate Therapeutics Inc公布了其针对难治性儿科癌症的一期临床试验的积极数据。试验结果显示,在治疗那些常规疗法效果不佳的棘手儿科癌症病例中,取得了令人鼓舞的患者预后成果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10